Deleterious Effects of Intermittent Recombinant Parathyroid Hormone on Cartilage Formation in a Rabbit Microfracture Model: a Preliminary Study
Intermittent parathyroid hormone administration can enhance fracture healing in an animal model. Despite the success of exogenous parathyroid hormone on fracture healing and spine fusion, few studies have examined the role of parathyroid hormone on cartilage formation. We determined the effects of intermittent parathyroid hormone on cartilage formation in a rabbit microfracture model of cartilage regeneration. Twelve rabbits were divided into three equal groups: (1) microfracture alone, (2) microfracture + parathyroid hormone daily for 7 days, and (3) microfracture + parathyroid hormone for 28 days. Nonoperated contralateral knees were used as controls. The animals were sacrificed at 3 months and gross and histologic analysis was performed. The microfracture alone group demonstrated the most healing on gross and histologic analysis. Treatment with either 1 or 4 weeks of parathyroid hormone inhibited cartilage formation. Although discouraging from a cartilage repair point of view, this study suggests that the role parathyroid hormone administration has in clinical fracture healing must be examined carefully. Although parathyroid hormone is beneficial to promote healing in spine fusion and midshaft fractures, its deleterious effects on cartilage formation suggests that it may have adverse effects on the outcomes of periarticular fractures such as tibial plateau injuries that require cartilage healing for a successful clinical outcome.
- Curl WW, Krome J, Gordon ES, Rushing J, et al. Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy. 1997; 13: 456–460. CrossRef
- Outerbridge RE. The etiology of chondromalacia patellae. J. Bone Joint Surg. Br. 1961; 43B: 752–757.
- Outerbridge RE, Dunlop JA, The etiology of chondromalacia patellae. Clin. Orthop. Rel. Res. 1975; 110: 177–196. CrossRef
- Gill TJ, The treatment of articular cartilage defects using microfracture and debridement. Am. J. Knee Surg. 2000; 13: 33–40.
- Steadman JR, Miller BS, Karas SG, et al. The microfracture technique in the treatment of full-thickness chondral lesions of the knee in National Football League players. J. Knee Surg. 2003; 16: 83–86.
- Williams RJ, 3rd, Harnly HW. Microfracture: indications, technique, and results. Instr. Course Lect. 2007; 56: 419–428
- Kreuz PC, Steinwachs MR, Erggelet C, et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthr. Cartil. 2006; 14: 1119–1125. CrossRef
- Mithoefer K, Williams RJ, 3rd, Warren RF, et al. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J. Bone Joint Surg. Am. 2005; 87: 1911–1920. CrossRef
- Gobbi A, Nunag P, Malinowski K. Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes. Knee Surg. Sports Traumatol. Arthrosc. 2005; 13: 213–221. CrossRef
- Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthr. Cartil. 2002; 10: 432–463. CrossRef
- Pineda S, Pollack A, Stevenson S, et al. A semiquantitative scale for histologic grading of articular cartilage repair. Acta Anat. (Basel). 1992; 143: 335–340. CrossRef
- Morgan EF, Mason ZD, Bishop G, et al. Combined effects of recombinant BMP-7 (rhBMP-7) and parathyroid hormone (1–34) in metaphyseal bone healing. Bone. 2008; 43: 1031–1038. CrossRef
- Mizuta H, Kudo S, Nakamura E, et al. Expression of the PTH/PTHrP receptor in chondrogenic cells during the repair of full thickness defects of articular cartilage. Osteoarthr. Cartil. 2006; 14: 944–952. CrossRef
- Bi W, Deng JM, Zhang Z, et al. Sox9 is required for cartilage formation. Nat. Genet. 1999; 22: 85–89. CrossRef
- Alkhiary YM, Gerstenfeld LC, Krall E, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34). J. Bone Joint Surg. Am. 2005; 7: 731–741. CrossRef
- Hashimoto T, Shigetomi M, Ohno T, et al. Sequential treatment with intermittent low-dose human parathyroid hormone (1–34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation. Calcif. Tissue Int. 2007; 81: 232–239. CrossRef
- Manabe T, Mori S, Mashiba T, et al. Human parathyroid hormone (1–34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone. 2007; 40: 1475–1482. CrossRef
- Kuo AC, Rodrigo JJ, Reddy AH, et al. Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair. Osteoarthr. Cartil. 2006; 14: 1126–1135. CrossRef
- Nakajima A, Shimoji N, Shiomi K, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J. Bone Miner. Res. 2002; 17: 2038–2047. CrossRef
- Lane JM, Gardner MJ, Lin JT, et al. The aging spine: new technologies and therapeutics for the osteoporotic spine. Eur Spine J. 2003; 12(Suppl 2): S147–S154. CrossRef
- Nozaka K, Miyakoshi N, Kasukawa Y, et al. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone. 2008; 42: 90–97. CrossRef
- Kudo S, Mizuta H, Otsuka Y, et al. Inhibition of chondrogenesis by parathyroid hormone in vivo during repair of full-thickness defects of articular cartilage. J. Bone Miner. Res. 2000; 15: 253–260. CrossRef
- Deleterious Effects of Intermittent Recombinant Parathyroid Hormone on Cartilage Formation in a Rabbit Microfracture Model: a Preliminary Study
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 6, Issue 1 , pp 79-84
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- parathyroid hormone
- Industry Sectors
- Author Affiliations
- 1. Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA
- 2. Department of Orthopaedic Surgery, University of California, San Francisco, 500 Parnassus Avenue, Millberry Union 320, San Francisco, CA, 94143, USA